Patents by Inventor MARY BETH SWITZER

MARY BETH SWITZER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS COMPRISING HETEROGENEOUS POPULATIONS OF RECOMBINANT HUMAN CLOTTING FACTOR XA PROTEINS
    Publication number: 20210106658
    Abstract: Compositions are provided comprising recombinant variants of the human clotting Factor Xa. Such compositions include a wide variety of isoforms and post-translational modifications of FXa and are useful for treating subjects in need of hemostasis.
    Type: Application
    Filed: May 25, 2020
    Publication date: April 15, 2021
    Inventors: KEITH A. JOHNSON, JASON C. ROUSE, PENELOPE JANE SHARPE, MICHAEL SHAMASHKIN, WENDY CAROL PIACENZA, MARY BETH SWITZER, STACEY B. WESTON, Michael Anthony JANKOWSKI
  • Methods for purifying FXa variant proteins
    Patent number: 10660946
    Abstract: Compositions are provided comprising recombinant variants of the human clotting Factor Xa. Such compositions include a wide variety of isoforms and post-translational modifications of FXa and are useful for treating subjects in need of hemostasis.
    Type: Grant
    Filed: August 4, 2017
    Date of Patent: May 26, 2020
    Assignee: Pfizer Inc.
    Inventors: Keith A. Johnson, Jason C. Rouse, Penelope Jane Sharpe, Michael Shamashkin, Wendy Carol Piacenza, Mary Beth Switzer, Stacey B. Weston, Michael Anthony Jankowski
  • COMPOSITIONS COMPRISING HETEROGENEOUS POPULATIONS OF RECOMBINANT HUMAN CLOTTING FACTOR XA PROTEINS
    Publication number: 20170333535
    Abstract: Compositions are provided comprising recombinant variants of the human clotting Factor Xa. Such compositions include a wide variety of isoforms and post-translational modifications of FXa and are useful for treating subjects in need of hemostasis.
    Type: Application
    Filed: August 4, 2017
    Publication date: November 23, 2017
    Inventors: KEITH A. JOHNSON, JASON C. ROUSE, PENELOPE JANE SHARPE, MICHAEL SHAMASHKIN, WENDY CAROL PIACENZA, MARY BETH SWITZER, STACEY B. WESTON, Michael Anthony JANKOWSKI
  • Method of weak partitioning chromatography
    Patent number: 9144755
    Abstract: This invention relates to methods of using weak partitioning chromatography for the purification of a product from a load fluid containing one or more impurities. Further, the invention relates to methods of weak partitioning chromatography defined by operating conditions which cause a medium to bind least 1 mg of product per mL of medium, or alternatively, defined by a partition coefficient of at least 0.1.
    Type: Grant
    Filed: November 28, 2011
    Date of Patent: September 29, 2015
    Assignee: Wyeth LLC
    Inventors: Paul R. Brown, Jonathan Lee Coffman, Ranganathan Godavarti, Timothy Iskra, Brian D. Kelley, Suresh Vunnum, Shujun Sun, Tianning Yu, James Edward Booth, Mary Beth Switzer
  • COMPOSITIONS COMPRISING HETEROGENEOUS POPULATIONS OF RECOMBINANT HUMAN CLOTTING FACTOR XA PROTEINS
    Publication number: 20150182604
    Abstract: Compositions are provided comprising recombinant variants of the human clotting Factor Xa. Such compositions include a wide variety of isoforms and post-translational modifications of FXa and are useful for treating subjects in need of hemostasis.
    Type: Application
    Filed: September 24, 2014
    Publication date: July 2, 2015
    Inventors: KEITH A. JOHNSON, JASON C. ROUSE, PENELOPE JANE SHARPE, MICHAEL SHAMASHKIN, WENDY CAROL PIACENZA, MARY BETH SWITZER, STACEY B. WESTON, Michael Anthony JANKOWSKI